Dietary Modification In Inflammatory Bowel Disease Patients
Launched by UNIVERSITY OF MALAYA · Mar 6, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special diet can help patients with Crohn's disease, a type of inflammatory bowel disease (IBD). Researchers are developing a diet that fits the cultural preferences of people in Malaysia, based on an existing diet known to help manage Crohn's disease symptoms. The trial will take place at the University Malaya Medical Centre and will look at how this diet affects patients' health and the bacteria in their gut over 24 weeks. Participants will have follow-up visits at 0, 6, 12, and 24 weeks, where they will provide stool and blood samples to help the researchers understand the diet's impact.
To be eligible for this study, participants must have a confirmed diagnosis of Crohn's disease and have mild to moderate symptoms. They should be between the ages of 65 and 74 or 18 and 262, and they must be willing to give their consent to join the study. However, individuals who have had recent surgery, have a stoma (an opening in the abdomen), or are currently on a specific nutritional plan called exclusive enteral nutrition (EEN) cannot participate. This study is not yet recruiting participants, but it aims to provide valuable insights into how dietary changes can improve the health of those living with Crohn's disease.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Confirmed diagnosis of Crohn's disease according to established clinical, endoscopic, and histological criteria.
- • Mild to moderate diseases (150 to 220 points).
- • Written informed consent obtained.
- Exclusion Criteria:
- • Presence of stoma.
- • Surgery within 6 months prior to randomization.
- • Patient on exclusive enteral nutrition (EEN).
About University Of Malaya
The University of Malaya, a premier research institution in Malaysia, is dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, the University collaborates with leading healthcare professionals and researchers to explore cutting-edge treatments and interventions. Its clinical trial programs focus on various health challenges, aiming to translate scientific discoveries into practical applications that benefit diverse populations. By fostering a multidisciplinary approach, the University of Malaya continues to contribute significantly to the global medical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kuala Lumpur, Petaling Jaya, Malaysia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported